Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 17942
Country/Region: Côte d'Ivoire
Year: 2017
Main Partner: Abt Associates
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $2,254,571 Additional Pipeline Funding: $656,710

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $51,000
Care: TB/HIV (HVTB) $139,726
Care: Pediatric Care and Support (PDCS) $1,469
Testing: HIV Testing and Counseling (HVCT) $593,260
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $7,137
Treatment: Adult Treatment (HTXS) $1,435,805
Treatment: Pediatric Treatment (PDTX) $26,174
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 246,231
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 1,905
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 827
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 703
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 12,246
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 7,997
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 4,530
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 990
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 1,103
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 9,558
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 7,936
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 9,986
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 9,026
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 110,195
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 58,811
HTS_TST Sum of Test Result disaggregates 2018 11,739
HTS_TST_POS By Test Result: Positive 2018 11,739
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 41
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 160
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 124
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 3,141
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 2,193
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 70
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 22
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 23
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 264
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 243
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 147
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 138
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 2,201
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 1,648
PMTCT_ART New on ART 2018 69
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 69
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 4,654
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 9
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 9
PMTCT_STAT By Age (Numerator): 25-49 2018 4,654
PMTCT_STAT By Number of known positives: 25-49 2018 56
PMTCT_STAT By Number of new negative: 25-49 2018 4,529
PMTCT_STAT By Number of new positives: 25-49 2018 69
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 4,654
PMTCT_STAT_den By Age (Denominator): 25-49 2018 4,654
TX_CURR Aggregated Age/Sex: <15 Female 2018 112
TX_CURR Aggregated Age/Sex: <15 Male 2018 111
TX_CURR Aggregated Age/Sex: 15+ Female 2018 6,899
TX_CURR Aggregated Age/Sex: 15+ Male 2018 5,649
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 12,771
TX_CURR Sum of Aggregated Age/Sex <15 2018 223
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 12,548
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 12,771
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 120
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 116
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 5,502
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 4,502
TX_NEW Breastfeeding status 2018 1
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 10,240
TX_NEW Pregnancy status 2018 51
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 10,240
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 9,860
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 8,850
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 79
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 82
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 4,779
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,909
TX_PVLS Numerator: Indication: Routine 2018 8,850
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 1
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 65
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 86
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 89
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 5,307
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 4,345
TX_PVLS_den Denominator: Indication: Routine 2018 9,847
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 1
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 63
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 29
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 29
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 539
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 461
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,058
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 1,202
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 32
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 32
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 619
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 519
TX_RET_den Denominator by Status: Pregnant 2018 7
Cross Cutting Budget Categories and Known Amounts Total: $16,000
Water $16,000